InvoX Pharma has acquired 1 company, including 1 in the last 5 years.
InvoX Pharma’s largest acquisition to date was in 2022, when it acquired F-star Therapeutics for $161M. The Company’s most targeted sectors include life science (100%).
5 Merchant Square,
London,
W2 1AY
United Kingdom,
+44 203 786 5144
www.invoxpharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2022-06-23 |
F-star Therapeutics · Life Science
Cambridge, United Kingdom · www.f-star.com F-star Therapeutics is a clinical-stage biopharmaceutical company pioneering bispecifics in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases, through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star Therapeutics is based in Cambridge, United Kingdom.
|
161
7.7x REVENUE |
Add-on Acquisition |
InvoX Pharma
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
